Plasma Fractionation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Plasma Fractionation Market Share & Size. The Market is Segmented by Product (immunoglobulins, Platelets, Coagulation Factor Concentrate, Albumin, and Other Products), Application (Neurology, Immunology, Hematology, and Other Applications), End-User (hospitals and Clinics, Clinical Research Laboratories, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value in (USD Million) for the Above Segments.

Plasma Fractionation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Plasma Fractionation Industry Overview

The plasma fractionation market is moderately competitive and consists of several major players. Companies like Bio Products Laboratory, China Biologic Products, CSL Behring, Grifols S.A., Takeda Pharmaceutical Company Ltd, Kedrion S.p.A, Octapharma, Shanghai RAAS Blood Products, among others, hold a substantial market share in the market. These significant companies in the market are engaging in partnerships, mergers, and acquisitions, aiming to strengthen their product portfolios and manufacturing capacities and provide competitive differentiation.

Plasma Fractionation Market Leaders

  1. CSL Behring

  2. Grifols S.A

  3. Octapharma

  4. Kedrion S.p.A

  5. Bio Products Laboratory

  6. *Disclaimer: Major Players sorted in no particular order
Plasma Fractionation Market Concentration

Plasma Fractionation Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?